Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
2801
-
2802
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2803
-
2804
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2805
-
2806
-
2807
-
2808
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2809
-
2810
-
2811
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2812
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2813
-
2814
-
2815
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2816
-
2817
-
2818
-
2819
-
2820